Skip to content

Quality of Life in Children With HIV Infection

Quality of Life in Children With HIV Infection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00075153
Enrollment
1993
Registered
2004-01-08
Start date
2001-09-30
Completion date
2008-07-31
Last updated
2014-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

ADOLESCENCE, HIV INFECTION, PEDIATRIC AIDS, QUALITY OF LIFE, HIV

Brief summary

The purpose of this study is to characterize the quality of life (QOL) and longitudinal patterns of change in QOL outcomes in children and youth with HIV infection; to identify demographic, social, disease status, treatment, and health care utilization factors that predict longitudinal changes in outcomes; to develop a conceptual model that characterizes the effects of specific factors that predict longitudinal changes in QOL; and to characterize the influence of HIV symptoms on QOL outcomes in the domains of health perceptions, physical, psychological, and social role functioning.

Detailed description

This is a Phase III study. This study will use national data available through a prospective, observational, longitudinal study of children and youth (n=1,993) from birth to 25 with HIV infection (Pediatric AIDS Clinical Trials Group Protocol 219/219C) to develop knowledge about the quality of life (QOL) and the factors that affect it in order to be able to implement effective nursing interventions and clinical programs to support and improve QOL in this vulnerable population of children.

Interventions

None listed

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
University of Medicine and Dentistry of New Jersey
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Months to 25 Years
Healthy volunteers
No

Inclusion criteria

* Children and youth with perinatally acquired HIV infection * Enrolled in PACTG 219/219C * Completed quality of life assessment

Exclusion criteria

--HIV exposed, not infected

Design outcomes

Primary

MeasureTime frame
Quality of Life assessment1999

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026